Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis

✍ Scribed by Marc C. Hochberg; Philip D. Ross; Dennis Black; Steven R. Cummings; Harry K. Genant; Michael C. Nevitt; Elizabeth Barrett-Connor; Thomas Musliner; Desmond Thompson

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: English
• Weight: 192 KB
• Volume: 42
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/1529-0131(199906)42:6<1246::aid-anr22>3.0.co;2-u